Patents/Assignees

Exelixis, Inc.

21 patents in portfolio

US12503438utility2025
Compounds for the Treatment of Kinase-dependent Disorders
0 cites
US12497367utility2025
Processes for the Preparation of a Kinase Inhibitor
0 cites
US12486233utility2025
Crystalline Solid Forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-n′-(4-fluorophenyl) Cyclopropane-1,1-dicarboxamide, Processes for Making, and Methods of Use
0 cites
US12371428utility2025
Pyridone Compounds and Methods of Use
0 cites
US12275706utility2025
Malate Salt of N-(4-{[6,7-bis(methyloxy) Quinolin-4-yl]oxy}phenyl)-n′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and Crystalline Forms Thereof for the Treatment of Cancer
0 cites
US12264161utility2025
Heterocyclic Adenosine Receptor Antagonists
0 cites
US12227481utility2025
Crystalline Solid Forms of Salts of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-n'-(4-fluorophenyl) Cyclopropane-1,1-dicarboxamide, Processes for Making, and Methods of Use
0 cites
US12195475utility2025
Compounds for the Treatment of Kinase-dependent Disorders
0 cites
US12128039utility2024
Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such Compounds
0 cites
US12084496utility2024
Anti-ror Antibody Constructs
0 cites
US12016854utility2024
Liquid Dosage Forms to Treat Cancer
0 cites
US12017995utility2024
Crystalline Forms and Salt Forms of a Kinase Inhibitor
0 cites
US11969419utility2024
Method of Treating Cancer
0 cites
US11760726utility2023
Crystalline Solid Forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl} -n'-(4-fluorophenyl) Cyclopropane-1,1-dicarboxamide, Processes for Making, and Methods of Use
0 cites
US11718622utility2023
Heterocyclic Adenosine Receptor Antagonists
0 cites
US11708367utility2023
Compounds for the Treatment of Kinase-dependent Disorders
0 cites
US11673897utility2023
Compounds for the Treatment of Kinase-dependent Disorders
0 cites
US11612597utility2023
Method of Treating Cancer
0 cites
US11597699utility2023
MEK Inhibitors and Methods of Their Use
0 cites
US11564915utility2023
Cabozantinib Dosage Form and Use in the Treatment of Cancer
0 cites

Page 1 of 2Next →